Literature DB >> 8719301

Effect of triiodothyronine administration in experimental myocardial injury.

R B Hsu1, T S Huang, Y S Chen, S H Chu.   

Abstract

Twelve healthy pigs were subjected to a 20-min, period of regional myocardial ischemia by snaring the left anterior descending coronary artery (LAD) between its first and second diagonal branches. The resulting myocardial injury caused significant acute hemodynamic impairments. Cardiac index declined significantly during reperfusion interval and returned to preischemic level by postoperative day 7. Plasma total triiodothyronine (TT3), free triiodothyronine (FT3) and free fatty acid (FFA) decreased gradually and reached the nadir at 6 h after LAD occlusion. In contrast, plasma reverse triiodothyronine (rT3) increased progressively after LAD occlusion and reperfusion. To investigate the effect of T3 on ischemic myocardium, T3 (0.2 microgram/kg/dose; n = 5) or saline (placebo; n = 6) was administered immediately, 30 min, 60 min, 90 min, and 120 min after reperfusion. Plasma TT3 and FT3 increased dramatically after triiodothyronine supplement but declined to presichemic level at six h after LAD occlusion. The pigs treated with T3 demonstrated a rapid improvement in cardiac index over the reperfusion interval, whereas cardiac index in the placebo group remained depressed. Myocardial oxygen consumption estimated by rate pressure product showed no difference between placebo and T3-treated groups. Oxygen extraction as O2 saturation difference between aorta and coronary sinus was less in T3-treated group. Nine pigs (four in the T3-treated group and five in the placebo group) were subjected to euthanasia with hypertonic KCl solution on postoperative day 7. Myocardial infarct size determined by triphenyltetrazolium chloride (TTC) tissue enzyme staining technique was not significantly different between T3-treated and placebo groups. We concluded that this animal model is a useful model of myocardial injury simulating "euthyroid sick syndrome" as seen in patients with cardiopulmonary bypass, and T3 supplementation after reperfusion significantly enhanced postischemic left ventricular functional recovery but did not affect myocardial oxygen consumption and myocardial infarct size.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719301     DOI: 10.1007/BF03349792

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Triiodothyronine therapy in the cardiac transplant recipient.

Authors:  D Novitzky; D K Cooper; N Zuhdi
Journal:  Transplant Proc       Date:  1988-10       Impact factor: 1.066

2.  Prolonged abnormalities of left ventricular diastolic wall thinning in the "stunned" myocardium in conscious dogs: time course and relation to systolic function.

Authors:  M L Charlat; P G O'Neill; C J Hartley; R Roberts; R Bolli
Journal:  J Am Coll Cardiol       Date:  1989-01       Impact factor: 24.094

3.  Acute severe postischemic myocardial depression reversed by triiodothyronine.

Authors:  F W Holland; P S Brown; R E Clark
Journal:  Ann Thorac Surg       Date:  1992-08       Impact factor: 4.330

Review 4.  Biochemical basis of thyroid hormone action in the heart.

Authors:  W H Dillmann
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

5.  Thyroid hormone changes after cardiovascular surgery and clinical implications.

Authors:  S H Chu; T S Huang; R B Hsu; S S Wang; C J Wang
Journal:  Ann Thorac Surg       Date:  1991-10       Impact factor: 4.330

6.  In vivo effect of 3,5,3'-triiodothyronine on calcium uptake in several tissues in the rat: evidence for a physiological role for calcium as the first messenger for the prompt action of thyroid hormone at the level of the plasma membrane.

Authors:  J Segal
Journal:  Endocrinology       Date:  1990-07       Impact factor: 4.736

7.  Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction.

Authors:  R G Gay; S Graham; M Aguirre; S Goldman; E Morkin
Journal:  Am J Physiol       Date:  1988-10

8.  Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats.

Authors:  M T Vivaldi; R A Kloner; F J Schoen
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

9.  Effects of thyroid hormone on calcium handling in cultured chick ventricular cells.

Authors:  D Kim; T W Smith
Journal:  J Physiol       Date:  1985-07       Impact factor: 5.182

10.  Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3'-triiodothyronine in sera of patients with nonthyroidal illnesses.

Authors:  I J Chopra; T S Huang; A Beredo; D H Solomon; G N Chua Teco; J F Mead
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

View more
  6 in total

Review 1.  "Non-thyroidal illness syndrome" is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge.

Authors:  L J DeGroot
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 2.  Thyroid Dysfunction and Heart Failure: Mechanisms and Associations.

Authors:  Hernando Vargas-Uricoechea; Anilza Bonelo-Perdomo
Journal:  Curr Heart Fail Rep       Date:  2017-02

Review 3.  Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses.

Authors:  Salvatore Sciacchitano; Carlo Capalbo; Christian Napoli; Paolo Anibaldi; Valentina Salvati; Claudia De Vitis; Rita Mancini; Flaminia Coluzzi; Monica Rocco
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-10       Impact factor: 6.055

4.  Clinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome.

Authors:  Kenan Iltumur; Gonul Olmez; Zuhal Ariturk; Tuncay Taskesen; Nizamettin Toprak
Journal:  Crit Care       Date:  2005-06-09       Impact factor: 9.097

5.  Prediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarction.

Authors:  Dong Hun Kim; Dong-Hyun Choi; Hyun-Wook Kim; Seo-Won Choi; Bo-Bae Kim; Joong-Wha Chung; Young-Youp Koh; Kyong-Sig Chang; Soon-Pyo Hong
Journal:  Korean J Intern Med       Date:  2014-06-27       Impact factor: 2.884

6.  Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury.

Authors:  Viswanathan Rajagopalan; Youhua Zhang; Christine Pol; Clifford Costello; Samantha Seitter; Ann Lehto; Olga V Savinova; Yue-Feng Chen; A Martin Gerdes
Journal:  Front Physiol       Date:  2017-04-12       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.